CGM, insulin pump players look to 2021 as watershed year for diabetes wearables market

Healthcare DIVE February 4, 2021
Ricky Zipp

The coronavirus pandemic has spurred an explosion in telehealth and digital health as patients stayed out of hospitals and doctors’ offices to slow the spread of the virus turned to virtual care.

As a result, the healthcare landscape has significantly changed over the past 10-11 months and companies are making moves to capitalize on the rise of tech-driven services and wearable devices.

Patients embraced devices like continuous glucose monitors and insulin pumps in recent years before the pandemic, and companies in these markets like Dexcom and Insulet or Medtronic and Abbott Laboratories have remained successful despite the economic volatility throughout 2020.

Now, Wall Street and industry see 2021 as a watershed moment for diabetes technology. Along with plans to expand...

Today's Sponsors

Today's Sponsor